Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junbo Ge

Showing results (1131-1140 of 1,174) with videos related to

Pageof 118
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2025
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programmeAngelo Oliva, Dominick J Angiolillo, Marco Valgimigli, et al.
Journal of the American College of Cardiology|October 8, 2025
Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position StatementSimone Fezzi, Patrick W Serruys, Bernardo Cortese, et al.
Journal of the American College of Cardiology|October 10, 2024
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized TrialMingtong Xu, Zhen Wang, Yumin Zhang, et al.
JACC. Cardiovascular Interventions|October 7, 2023
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCIMarco Valgimigli, Alessandro Spirito, Samantha Sartori, et al.
Nature|January 21, 2026
Fibre integrated circuits by a multilayered spiral architectureZhen Wang, Ke Chen, Xiang Shi, et al.
The American Journal of Cardiology|January 7, 2024
1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global ProgramGennaro Sardella, Alessandro Spirito, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|July 13, 2026
Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR ScoreDavide Cao, Angelo Oliva, Roxana Mehran, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
European Heart Journal|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
European Heart Journal|August 22, 2020
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)Matteo Serenelli, Michael Böhm, Silvio E Inzucchi, et al.
Pageof 118

Showing results (1131-1140 of 1,174) with videos related to

Sort By:
Pageof 118
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2025
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programmeAngelo Oliva, Dominick J Angiolillo, Marco Valgimigli, et al.
Journal of the American College of Cardiology|October 8, 2025
Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position StatementSimone Fezzi, Patrick W Serruys, Bernardo Cortese, et al.
Journal of the American College of Cardiology|October 10, 2024
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized TrialMingtong Xu, Zhen Wang, Yumin Zhang, et al.
JACC. Cardiovascular Interventions|October 7, 2023
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCIMarco Valgimigli, Alessandro Spirito, Samantha Sartori, et al.
Nature|January 21, 2026
Fibre integrated circuits by a multilayered spiral architectureZhen Wang, Ke Chen, Xiang Shi, et al.
The American Journal of Cardiology|January 7, 2024
1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global ProgramGennaro Sardella, Alessandro Spirito, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|July 13, 2026
Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR ScoreDavide Cao, Angelo Oliva, Roxana Mehran, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
European Heart Journal|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
European Heart Journal|August 22, 2020
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)Matteo Serenelli, Michael Böhm, Silvio E Inzucchi, et al.
Pageof 118